N/A
N=512
Adherence Support Intervention for Persons Living With HIV/AIDS (PLWHA) on Antiretroviral Therapy (ART) in Estonia
HIV · AIDS · Medication Adherence
Bottom Line
View on ClinicalTrials.gov: NCT01789138 ↗Enrolled (actual)
512
Serious AEs
0.0%
Results posted
Feb 2016
Primary outcome: Primary: Antiretroviral Therapy (ART) Adherence (Self-reported 3-day Recall Measure) — 142; 139; 6; 12 participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Situated Optimal Adherence Intervention (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Tartu
- Primary completion
- Nov 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Antiretroviral Therapy (ART) Adherence (Self-reported 3-day Recall Measure) |
142; 139; 6; 12; 0; 8 | — |
| SECONDARY HIV-1 RNA Count / Viral Load (VL) |
62; 53; 7; 6; 30; 37 | — |
Summary
The specific aim of the study is to assess antiretroviral therapy adherence and evaluate the impact of a situated treatment adherence intervention program among persons living with HIV/AIDS on antiretroviral therapy in Estonia.
Eligibility Criteria
Inclusion Criteria
- HIV infected
- aware of the HIV-positive status for at least 3 months
- ≥ 18 years of age
- speak and read either Estonian or Russian
- receive or start (on recruitment date) antiretroviral therapy
Exclusion Criteria
- pregnant
- under the influence of alcohol or (illicit)drugs
Data sourced from ClinicalTrials.gov (NCT01789138). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.